Literature DB >> 14566461

[Treatment of glomerulonephritis].

T Risler1, N Braun, C M Erley.   

Abstract

The treatment of primary glomerulonephritis is a complex matter because of an unclear clinical picture. Glomerulonephritis may emerge as acute nephritis, nephrotic syndrome or minor proteinuria or hematuria. The symptomatic treatment may be derived from the clinical status; immunosuppressive therapy has to be substantiated by renal biopsy in order to offer the best choice to the patient.Rapid-progressive glomerulonephritis must be treated aggressively, as early as possible, to prevent chronic renal failure. Nephrotic syndrome should be treated symptomatically. Immunosuppressants are indicated according to the histological picture and accompanying clinical risk factors for progressive renal disease, which have to be evaluated before treatment. This paper gives the current strategies for treating primary glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14566461     DOI: 10.1007/s00108-003-1029-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  44 in total

1.  Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure.

Authors:  D Fouque; P Wang; M Laville; J P Boissel
Journal:  Nephrol Dial Transplant       Date:  2000-12       Impact factor: 5.992

2.  Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.

Authors:  Francis W Ballardie; Ian S D Roberts
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

3.  Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.

Authors:  Y Kanno; H Okada; T Saruta; H Suzuki
Journal:  Clin Nephrol       Date:  2000-11       Impact factor: 0.975

Review 4.  Renal complications of nonsteroidal anti-inflammatory drugs.

Authors:  D Schlondorff
Journal:  Kidney Int       Date:  1993-09       Impact factor: 10.612

Review 5.  Alternative treatments for focal and segmental glomerular sclerosis.

Authors:  C Ponticelli; P Passerini
Journal:  Clin Nephrol       Date:  2001-05       Impact factor: 0.975

6.  Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.

Authors:  Alvaro Torres; Beatriz Domínguez-Gil; Agustín Carreño; Eduardo Hernández; Enrique Morales; Julian Segura; Ester González; Manuel Praga
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

7.  Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.

Authors:  J B Levy; A N Turner; A J Rees; C D Pusey
Journal:  Ann Intern Med       Date:  2001-06-05       Impact factor: 25.391

8.  Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?

Authors:  C Ponticelli; M Villa; G Banfi; B Cesana; C Pozzi; A Pani; P Passerini; M Farina; C Grassi; A Baroli
Journal:  Am J Kidney Dis       Date:  1999-10       Impact factor: 8.860

9.  Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course.

Authors:  K Andrassy; S Küster; R Waldherr; E Ritz
Journal:  Nephron       Date:  1991       Impact factor: 2.847

10.  The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.

Authors:  S Klahr; A S Levey; G J Beck; A W Caggiula; L Hunsicker; J W Kusek; G Striker
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.